Hi Tommy,
Thanks for this - it would be better if they addressed the cardiocel separately in the quarterly. If correct the 1 million per quarter would be a great result imo, with 1 million sales quoted by the company for the first six months.
Revenue for the pcp quarter 1.7 million - so 2.5 with a slight drop in the other part of the business sounds feasible.
Quarterly, page-104
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.00 | $18.00 | $4.374K | 243 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.22 | 11 | 1 |
View Market Depth
| Last trade - 09.59am 16/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |